Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
Mallinckrodt
Merck
Baxter
Teva

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 7,608,723

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,608,723
Title:Indole and benzimidazole derivatives
Abstract: The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: ##STR00001##
Inventor(s): Boyce; Rustum S. (Singapore, CN), Xia; Yi (Palo Alto, CA), Guo; Hongyan (Foster City, CA), Mendenhull; Kris G. (Concord, CA), Walter; Annette O. (Mill Valley, CA), Wang; Weibo (Moraga, CA)
Assignee: Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA)
Application Number:11/251,440
Patent Claims:see list of patent claims

Details for Patent 7,608,723

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2024-10-19 RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2024-10-19 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,608,723

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2006049835 May 11, 2006
World Intellectual Property Organization (WIPO) 2006049835 Nov 22, 2007
United States of America 2006084687 Apr 20, 2006
United States of America 2008317744 Dec 25, 2008
United States of America 8008335 Aug 30, 2011
Russian Federation 2007118523 Nov 27, 2008
Mexico 2007004699 Jun 14, 2007
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Covington
Fish and Richardson
Colorcon
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.